Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale - Lopes, RD; Alexander, JH; Al-Khatib, SM (Am Heart J, 2010)
et al.